Trial intelligence / Profile preview

Safety of Repevax Administered One Month After Revaxis or Placebo

NCT00400309Phase 3Completed

Sponsor
Sanofi
Start
Jun 2006
Primary completion
Feb 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Adacel Polio in Tetanus, diphtheria, pertussis, poliomyelitis, sponsored by Sanofi. Started Jun 2006; status: completed.

02

Drugs

Adacel Polio
03

Conditions

Tetanusdiphtheriapertussispoliomyelitis

Beyond the preview

Go deeper on NCT00400309.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00400309.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call